OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2022
(4)
2025
(2)
2023
(2)
2021
(2)
2016
(2)
2024
(1)
2020
(1)
2019
(1)
2015
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Not available
S-EPMC6459115
|
biostudies-literature
Cite
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Not available
S-EPMC4872347
|
biostudies-literature
Cite
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.
Not available
S-EPMC9807004
|
biostudies-literature
Cite
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies.
Not available
S-EPMC5465643
|
biostudies-literature
Cite
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.
Not available
S-EPMC9662946
|
biostudies-literature
Cite
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.
Not available
S-EPMC2948179
|
biostudies-literature
Cite
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.
Not available
S-EPMC9406237
|
biostudies-literature
Cite
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer.
Not available
S-EPMC12094577
|
biostudies-literature
Cite
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.
Not available
S-EPMC8425833
|
biostudies-literature
Cite
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Not available
S-EPMC10711502
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets